Nevro Enterprise Value Over E B I T D A from 2010 to 2025

NVRO Stock  USD 5.79  0.02  0.35%   
Nevro Corp Enterprise Value Over EBITDA yearly trend continues to be very stable with very little volatility. Enterprise Value Over EBITDA is likely to drop to -2.45. During the period from 2010 to 2025, Nevro Corp Enterprise Value Over EBITDA quarterly data regression pattern had range of 187 and standard deviation of  46.23. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(2.33)
Current Value
(2.45)
Quarterly Volatility
46.23315243
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nevro Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nevro Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.8 M, Interest Expense of 28.2 M or Selling General Administrative of 225 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.0 or PTB Ratio of 0.57. Nevro financial statements analysis is a perfect complement when working with Nevro Corp Valuation or Volatility modules.
  
Check out the analysis of Nevro Corp Correlation against competitors.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

Latest Nevro Corp's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Nevro Corp over the last few years. It is Nevro Corp's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nevro Corp's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Very volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Nevro Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(24.81)
Coefficient Of Variation(186.35)
Mean Deviation33.72
Median(5.51)
Standard Deviation46.23
Sample Variance2,138
Range187
R-Value0.01
Mean Square Error2,290
R-Squared0.0001
Significance0.97
Slope0.11
Total Sum of Squares32,063

Nevro Enterprise Value Over E B I T D A History

2025 -2.45
2024 -2.33
2023 -11.39
2022 70.18
2021 -28.86
2020 -117.08
2019 -44.82

About Nevro Corp Financial Statements

Nevro Corp investors utilize fundamental indicators, such as Enterprise Value Over E B I T D A, to predict how Nevro Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(2.33)(2.45)
When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock:
Check out the analysis of Nevro Corp Correlation against competitors.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.06)
Revenue Per Share
11.015
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.1)
Return On Equity
(0.43)
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.